Tamoxifen therapy for patients with breast cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Lancet

• Publication date

  2013-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(13)61237-4PMID 23769226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

  2013cited by this paper
• American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

  2010cited by this paper
• American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

  2010cited by this paper
• Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

  2008cited by this paper
• Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

  2005cited by this paper

• Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer

  2025cites this paper
• CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis

  2019cites this paper
• PRRX 1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells

  2018cites this paper
• Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

  2015cites this paper
• The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer

  2015cites this paper
• Measuring persistence to hormonal therapy in patients with breast cancer: accounting for temporary treatment discontinuation

  2014cites this paper
• Zielgerichtete Therapien in der Behandlung des Mammakarzinoms

  2013cites this paper